Exozymes Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Heltzen Michael, was filed 02 Jul 2025.
Exozymes Inc.: what insiders have been doing
Exozymes Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). 4 insiders have disclosed 11 filings since 26 October 2025.
Only sales appear on the open market, 3 sales in all totalling €31k, filed by 2 insiders. Biggest ticket of the year: €17k, sold by Perriman Damien Alan and made public on 26 October 2026.
Across the 3,167 companies tracked on its exchange, the median is 24 filings; at 11 filings, this issuer sits below that mark. Looking back to 2024, when coverage begins, insiders filed 4 purchases and 3 sales.
Typically, a trade is published a median of 7 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -17.9%Entry US$9.91 · Close at T+365 US$8.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 3,922 sharesCommon StockSEC:0001493152-26-048493:0
- 3,729 shares@ US$5.2096Common StockSEC:0001493152-26-048493:1
- 19,612 sharesCommon StockSEC:0001493152-26-040129:0
- 32,964 sharesCommon StockSEC:0001493152-26-040116:0
- 750 shares@ US$10.04067.6% of flowCOMMON STOCKSEC:0001493152-26-016166:0
- 750 shares@ US$10.5258.0% of flowCOMMON STOCKSEC:0001493152-26-016166:1
- 62,759 shares0Restricted Stock Grant for Common StockSEC:0001493152-26-015761:0
- 5,332 shares@ US$8.4446.0% of flowCOMMON STOCKSEC:0001493152-26-015619:0
- 5,999 shares@ US$8.4453.7% of flowCOMMON STOCKSEC:0001493152-26-015622:0
- 3,999 shares@ US$8.4447.4% of flowCOMMON STOCKSEC:0001493152-26-015627:0
- 8,887 shares@ US$8.44100.0% of flowCOMMON STOCKSEC:0001493152-26-015630:0
- 1,040 shares@ US$10.22100.0% of flowCommon StockSEC:0001641172-25-017630:0Canonical exit: 30 Sept 2025 (T+90)
- 2,990 shares@ US$12.5438.4% of flowCommon StockSEC:0001641172-25-015460:0
- 2,990 shares@ US$12.5452.6% of flowCommon StockSEC:0001641172-25-015458:0
- 3,489 shares@ US$12.5446.3% of flowCommon StockSEC:0001641172-25-015456:0
- 1,767 shares@ US$10.7837.2% of flowCommon StockSEC:0001493152-25-002875:1Canonical exit: 17 Apr 2025 (T+90)
- 121 shares@ US$10.725.7% of flowCommon StockSEC:0001493152-25-002875:0Canonical exit: 16 Apr 2025 (T+90)
- 1,984 shares@ US$11.1094.3% of flowCommon StockSEC:0001493152-24-046902:0Canonical exit: 13 Feb 2025 (T+90)
- 122,657 shares@ US$6.40100.0% of flowCommon StockSEC:0001493152-24-046627:0
- 2,344 shares@ US$6.40100.0% of flowCommon StockSEC:0001493152-24-046629:0
20 of 20 declarations
About Exozymes Inc.
Exozymes Inc. is a NASDAQ-listed company focused on developing enzymatic solutions. It emphasizes innovation in the biotechnology sector.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
